🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Tablet-based Mobile Health Ultrasound for Point-of-care Breast Cancer Diagnosis in Nigeria (Mobile Health: Technology and Outcomes in Low and Middle-Income Countries)

Recruitingn/aAges 18 Years - anyFemaleMemorial Sloan Kettering Cancer Center
NCT05561842 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The purpose of this study is to train Nigerian radiologists to perform ultrasound-guided breast biopsies. Researchers will use mHealth devices to create a sustainable and practical way of training radiologists in Nigeria to perform and clinically implement US-guided breast biopsies into their practice.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Age 18 and older female. * Breast ultrasound demonstrating a solid mass that is suspicious for cancer, which would typically undergo either a blind biopsy or surgical excision at the Nigerian hospital where the patient is seeking diagnosis. Exclusion Criteria: * Participants unwilling to sign consent. * Participants under the age of 18.
💊

What it tests

  • mHealth US-breast biopsy
📍

Where

8 sites
Memorial Sloan Kettering Cancer Center (All Protocol Activities)
New York, United States
Lagos University Teaching Hospital
Idi-Araba, Nigeria
Olabisis Onabanjo University Teaching Hospital (Data Collection Only)
Sagamu, Nigeria
Federal Medical Centre Owo (Data Collection Only)
Owo, Nigeria
University College Hospital (Data Collection Only)
Ibadan, Nigeria
University Of Nigeria Teaching Hospital (UNTH) Ituku-Ozalla Enugu
Enugu, Nigeria
Obafemi Awolowo University Teaching Hospitals Complex (Data Collection Only)
Ile-Ife, Nigeria
University of Ilorin Teaching Hospitals
Ilorin, Nigeria
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy